Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Andrew D. Zelenetz | Researchclopedia

Back to researchers

Andrew D. Zelenetz

Memorial Sloan Kettering Cancer Center ORCID

757

Works

42,721

Citations

96

h-index

318

i10-index

Research Topics

Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research Viral-associated cancers and disorders

Affiliations

Nihon University2012–2012

Ontario Institute for Cancer Research2003–2003

Roche (Switzerland)2010–2020

Rush University Medical Center2004–2004

Lahey Hospital and Medical Center2009–2009

Top Works

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

Steven H. Swerdlow,Elı́as Campo,et al.

20167,726 citations

Lung Cancer Treatments and Mutations

CNS Lymphoma Diagnosis and Treatment

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

Roland Schmitz,George W. Wright,et al.

20182,199 citations

Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia

Richard R. Furman,Jeff P. Sharman,et al.

20141,676 citations

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

Elı́as Campo,Elaine S. Jaffe,et al.

20221,392 citations

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

Zheng Zhou,Laurie H. Sehn,et al.

2013944 citations

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

Kenneth R. Carson,Andrew M. Evens,et al.

2009868 citations

Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study

Carla Casulo,Michelle Byrtek,et al.

2015830 citations

Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-Refractory Low-Grade or Transformed Low-Grade B-Cell Non-Hodgkin’s Lymphomas

Mark Kaminski,Andrew D. Zelenetz,et al.

2001585 citations

Phase II Clinical Experience With the Novel Proteasome Inhibitor Bortezomib in Patients With Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma

Owen A. O’Connor,James R. Wright,et al.

2004579 citations